Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.85 CHF | -0.73% | +1.72% | +4.70% |
12:32pm | Morphosys says takeover by Novartis on course after report of drug safety concern | RE |
04-26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.70% | 200B | |
+25.56% | 661B | |
+26.74% | 566B | |
-6.54% | 352B | |
+20.26% | 332B | |
+3.07% | 283B | |
+13.38% | 231B | |
-9.41% | 195B | |
-5.18% | 145B | |
-10.61% | 144B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Zacks Lifts Price Target on Novartis, Maintains Neutral Recommendation